Neuronetics Affirms FY2026 Sales Guidance of $160.000M-$164.000M vs $162.025M Est
Benzinga Newsdesk 17 hours ago
NewsGuidance
Neuronetics (NASDAQ:STIM) affirms FY2026 sales outlook from $160.000 million-$164.000 million to $160.000 million-$164.000 million vs $162.025 million estimate.
Neuronetics (NASDAQ:STIM) affirms FY2026 sales outlook from $160.000 million-$164.000 million to $160.000 million-$164.000 million vs $162.025 million estimate.